V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20165143 | 20063379 | 1.7 | 80.6 | Palliative (P) | 2016-08-31 | 2016-09-11 | ECX | N | N | ECX | 101766579 |
| 20165149 | 20063380 | 1.65 | 47.6 | Neo-adjuvant (N) | 2020-01-13 | 2020-01-21 | ECX | 02 | N | ECX | 101152139 |
| 20165162 | 20063381 | 1.82 | null | Curative (C) | 2016-11-15 | 2016-11-25 | ECX | N | N | ECX | 101104650 |
| 20165164 | 20063382 | 1.67 | 35.3 | Curative (C) | 2018-06-10 | 2018-06-24 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100270095 |
| 20165165 | 20063383 | 1.55 | 89.3 | Adjuvant (A) | 2019-11-28 | 2019-12-04 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100728270 |
| 20165176 | 20063384 | 1.77 | 68.2 | Neo-adjuvant (N) | 2017-05-13 | 2017-05-21 | ECX | N | N | ECX | 101772714 |
| 20165187 | 20063385 | 1.65 | 63.2 | Curative (C) | 2017-08-13 | 2017-08-13 | ECX | 02 | null | ECX | 100477971 |
| 20165188 | 20063386 | 1.62 | 51.1 | Neo-adjuvant (N) | null | 2019-02-20 | ECX | N | N | ECX | 100502578 |
| 20165189 | 20063387 | 1.84 | 71 | Adjuvant (A) | 2016-05-19 | 2016-05-30 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 100695892 |
| 20165190 | 20063388 | 1.68 | 88 | Palliative (P) | 2017-01-15 | 2017-01-15 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101701715 |
| 20165193 | 20063389 | 1.56 | 102 | Palliative (P) | 2020-02-28 | 2020-03-01 | ECX | N | N | ECX | 100217401 |
| 20165196 | 20063390 | 1.62 | 78 | Curative (C) | 2017-03-31 | 2017-04-27 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 100275895 |
| 20165200 | 20063391 | 1.6 | 72 | null | 2017-08-17 | 2017-08-24 | ECX | N | N | CAPECITABINE + GEMCITABINE | 101520860 |
| 20165222 | 20063392 | 1.63 | 62.4 | Adjuvant (A) | 2012-01-20 | 2017-02-16 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101563270 |
| 20165225 | 20063393 | 1.86 | 81 | Curative (C) | null | 2017-08-25 | Gemcitabine + Capecitabine | null | N | CAPECITABINE + GEMCITABINE | 100357059 |
| 20165231 | 20063394 | null | null | Palliative (P) | 2019-10-22 | 2019-10-23 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100944906 |
| 20165232 | 20063395 | 1.6 | 76 | Adjuvant (A) | 2019-08-04 | 2019-08-06 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100223272 |
| 20165240 | 20063396 | null | null | Neo-adjuvant (N) | 2018-02-25 | 2018-03-02 | ECX | 02 | N | ECX | 100189550 |
| 20165248 | 20063397 | 1.8 | 77.3 | Palliative (P) | 2016-02-27 | 2016-03-15 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100429854 |
| 20165252 | 20063398 | 1.6 | 57.3 | Adjuvant (A) | 2017-12-02 | 2017-12-16 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101733739 |
| 20165255 | 20063399 | 1.52 | 86 | Neo-adjuvant (N) | 2018-01-12 | 2018-01-13 | ECX | 2 | N | ECX | 101455353 |
| 20165258 | 20063400 | 1.73 | 63 | Neo-adjuvant (N) | 2018-02-02 | 2018-02-16 | ECX | N | N | ECX | 100712795 |
| 20165264 | 20063401 | 1.84 | 82.2 | Neo-adjuvant (N) | 2016-07-28 | 2016-07-30 | ECX | N | N | ECX | 100725897 |
| 20165265 | 20063402 | 1.74 | 79.2 | Neo-adjuvant (N) | 2016-07-27 | 2016-08-05 | ECX | 02 | N | ECX | 101620574 |
| 20165269 | 20063403 | 1.8 | 80 | Palliative (P) | 2018-05-04 | 2018-05-09 | ECX | 2 | N | ECX | 101685428 |
| 20165275 | 20063404 | 1.75 | 71.6 | Palliative (P) | 2019-02-15 | 2019-03-01 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101338332 |
| 20165276 | 20063405 | 1.62 | 58.2 | Adjuvant (A) | 2020-02-10 | 2020-02-11 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101763475 |
| 20165288 | 20063406 | 1.76 | 72.8 | null | 2018-03-25 | 2018-04-07 | ECX | null | N | ECX | 100611725 |
| 20165294 | 20063407 | 1.66 | 86 | Adjuvant (A) | 2017-06-22 | 2017-07-06 | ECX | N | N | ECX | 100274698 |
| 20165297 | 20063408 | 1.49 | 50 | Palliative (P) | 2017-09-06 | 2017-09-06 | ECX | 2 | N | ECX | 100730062 |
| 20165309 | 20063409 | null | 84.4 | Neo-adjuvant (N) | 2016-10-27 | 2016-11-06 | ECX | N | N | ECX | 101682381 |
| 20165311 | 20063410 | 1.6 | 52.9 | Curative (C) | 2020-01-09 | 2020-01-22 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101001790 |
| 20165315 | 20063411 | 1.78 | 57.3 | Neo-adjuvant (N) | 2018-08-03 | 2018-08-25 | ECX | N | N | ECX | 101225556 |
| 20165322 | 20063412 | 1.83 | 109.7 | null | 2016-03-07 | 2016-03-20 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101507526 |
| 20165325 | 20063413 | 1.56 | 79 | Adjuvant (A) | 2018-12-25 | 2019-01-03 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100800173 |
| 20165327 | 20063414 | 1.52 | 86.9 | Adjuvant (A) | 2017-04-02 | 2017-04-17 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100522683 |
| 20165328 | 20063415 | 1.66 | 64 | Adjuvant (A) | 2016-02-22 | 2016-03-17 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101536008 |
| 20165336 | 20063416 | 1.53 | 36 | Neo-adjuvant (N) | 2017-06-02 | 2017-06-08 | ECX | 2 | N | ECX | 100553487 |
| 20165340 | 20063417 | 1.54 | 78.95 | Palliative (P) | 2019-08-14 | 2019-08-16 | ECX | 02 | Y | ECX | 100482096 |
| 20165345 | 20063418 | 1.72 | 71 | Adjuvant (A) | 2016-10-27 | 2016-11-07 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101649040 |
| 20165346 | 20063419 | 1.71 | 101.2 | Palliative (P) | 2017-10-05 | 2017-10-12 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100207280 |
| 20165353 | 20063420 | null | null | Curative (C) | 2016-09-16 | 2016-09-24 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100879431 |
| 20165356 | 20063421 | 1.73 | 83 | Palliative (P) | 2018-07-25 | 2018-07-27 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100325453 |
| 20165359 | 20063422 | 1.6 | 59 | Neo-adjuvant (N) | 2017-08-20 | 2017-09-02 | ECX | 02 | N | ECX | 101662739 |
| 20165364 | 20063423 | 1.6 | 70 | Neo-adjuvant (N) | 2017-05-06 | 2017-05-07 | ECX | 02 | N | ECX | 101610810 |
| 20165365 | 20063424 | 1.81 | 57.3 | Curative (C) | 2016-11-22 | 2016-11-22 | Gemcitabine + Capecitabine | N | N | ECX | 100926976 |
| 20165367 | 20063425 | 1.78 | 71.1 | Curative (C) | 2017-07-24 | 2017-08-07 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100082994 |
| 20165375 | 20063426 | 1.6 | 67.8 | Curative (C) | 2018-06-18 | 2018-06-18 | ECX | N | Y | ECX | 100469211 |
| 20165380 | 20063427 | 1.75 | 126.9 | Neo-adjuvant (N) | 2018-08-02 | 2018-08-07 | ECX | N | null | ECX | 101440155 |
| 20165389 | 20063428 | 1.67 | 89 | Palliative (P) | 2019-05-21 | 2019-05-30 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101553513 |